Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
Fountzilas G, Daniilidis J, Sridhar KS, Kalogera-Fountzila A, Zaramboukas T, Sombolos K, Destouni-Salem E, Vritsios A, Tourkantonis A. Fountzilas G, et al. Among authors: daniilidis j. Cancer. 1990 Oct 1;66(7):1453-60. doi: 10.1002/1097-0142(19901001)66:7<1453::aid-cncr2820660703>3.0.co;2-x. Cancer. 1990. PMID: 1698526
Platinum-based induction chemotherapy followed by radiation as definitive treatment for patients with locally advanced cancer of the oral cavity, oropharynx and hypopharynx. A retrospective analysis of 32 cases.
Fountzilas G, Daniilidis J, Kosmidis P, Sridhar KS, Kalogera-Fountzila A, Banis K, Avramidis V, Tsavdaridis D, Themelis C, Zaramboukas T, et al. Fountzilas G, et al. Among authors: daniilidis j. J Chemother. 1991 Jun;3(3):183-8. doi: 10.1080/1120009x.1991.11739090. J Chemother. 1991. PMID: 1919657
Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
Fountzilas G, Nicolaou A, Sridhar K, Sideras T, Haritanti A, Anastasakis C, Delis V, Vritsios A, Daniilidis J. Fountzilas G, et al. Among authors: daniilidis j. Arch Otorhinolaryngol. 1989;246(5):373-7. doi: 10.1007/BF00463598. Arch Otorhinolaryngol. 1989. PMID: 2480104 Clinical Trial.
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Janinis J, Stathopoulos GP, Nikolaidis P, Kalofonos HP, Kalogera-Fountzila A, Samantas E, Aravantinos G, Anagnostopoulos A, Tolis C, Makatsoris T, Rigatos SK, Bafaloukos D, Dimopoulos MA, Daniilidis J, Fountzilas G. Janinis J, et al. Among authors: daniilidis j. Anticancer Drugs. 2004 Jun;15(5):479-87. doi: 10.1097/01.cad.0000127662.81719.86. Anticancer Drugs. 2004. PMID: 15166622 Clinical Trial.
Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study.
Fountzilas G, Ciuleanu E, Dafni U, Plataniotis G, Kalogera-Fountzila A, Samantas E, Athanassiou E, Tzitzikas J, Ciuleanu T, Nikolaou A, Pantelakos P, Zaraboukas T, Zamboglou N, Daniilidis J, Ghilezan N. Fountzilas G, et al. Among authors: daniilidis j. Med Oncol. 2004;21(2):95-107. doi: 10.1385/MO:21:2:095. Med Oncol. 2004. PMID: 15299181 Clinical Trial.
58 results